title: Treatment of Lymph Node-Negative, Early-Stage HER2-Positive Breast Cancer.
authors.affiliation: Baskent University, Bahcelievler/Ankara, Turkey oguzarzu@yahoo.com.
authors.forename: Arzu
authors.initials: A
authors.lastname: Oguz
authors.affiliation: Baskent University, Bahcelievler/Ankara, Turkey.
authors.forename: Gul Sema
authors.initials: GS
authors.lastname: Keskin
authors.affiliation: Baskent University, Bahcelievler/Ankara, Turkey.
authors.forename: Dilsen
authors.initials: D
authors.lastname: Colak
authors.affiliation: Baskent University, Bahcelievler/Ankara, Turkey.
authors.forename: Ozden
authors.initials: O
authors.lastname: Altundag
authors.affiliation: Baskent University, Bahcelievler/Ankara, Turkey.
authors.forename: Zafer
authors.initials: Z
authors.lastname: Akcali
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000201:enzymology*; D005260:Female; D006801:Humans; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000096:biosynthesis*
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D018719:Erb-b2 Receptor Tyrosine Kinases